🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dermatomyositis

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies NCT06698796Phase 326 sites📍 Glendale📍 Frisco📍 Houston Pfizer · Tests: Dazukibart Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES NCT07265999n/a1 site📍 Pointe-à-Pitre Centre Hospitalier Universitaire de la Guadeloupe Baricitinib in Patients With Relapsing or naïve Dermatomyositis NCT04972760Phase 31 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Baricitinib, Placebo Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis NCT06569472Phase 11 site📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CD19-targetd CAR-T Adult and Juvenile Myositis NCT00017914n/a4 sites📍 Atlanta📍 Bethesda📍 Research Triangle Park National Institute of Environmental Health Sciences (NIEHS) A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease NCT07085104Phase 117 sites📍 Phoenix📍 Loma Linda📍 Aurora Allogene Therapeutics · Tests: ALLO-329, Cyclophosphamide, Fludarabine Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases NCT06732674NA1 site📍 Oslo Oslo University Hospital · Tests: A home monitoring strategy with event driven management Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders NCT07089121Phase 1, Phase 23 sites📍 Washington D.C.📍 St Louis📍 Cincinnati Cartesian Therapeutics · Tests: Descartes-08 Optimizing Treatment on Idiopathic Inflammatory Myopathies NCT03092180n/a1 site📍 São Paulo University of Sao Paulo · Tests: Intravenous Infusion FT839 in Autoimmune Diseases NCT07800871Phase 1, Phase 21 site📍 Fullerton Fate Therapeutics · Tests: FT839 Panniculitis in Dermatomyositis NCT07345949n/a1 site📍 Strasbourg University Hospital, Strasbourg, France RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy NCT06154252Phase 2, Phase 338 sites📍 Orange📍 San Francisco📍 Aurora Cabaletta Bio · Tests: CABA-201 following preconditioning with fludarabine and cyclophosphamide Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty NCT07138898Phase 21 site📍 New York NYU Langone Health · Tests: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide, Azathioprine Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial NCT06919380Phase 11 site📍 Guangzhou Li Shiyue · Tests: MSC-exos Nebulization Therapy Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) NCT06686524Phase 11 site📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: Anti-CD19 UCAR-T cells MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) NCT07374107n/a1 site📍 New Orleans Myositis International Health & Research Collaborative Alli… · Tests: No intervention - qualitative and mixed methods investigations Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases NCT06387654n/a1 site📍 Toulouse University Hospital, Toulouse · Tests: Blood sampling, Remainders of samples taken as part of the treatment Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases NCT06599411n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Sampling, Sampling Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) NCT06371417Phase 177 sites📍 Orange📍 Baltimore📍 Lake Success Chugai Pharmaceutical · Tests: RAY121 Rheumatology Patient Registry and Biorepository NCT04402086n/a1 site📍 New Haven Yale University Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study NCT07486869Phase 21 site📍 Miami University of Miami · Tests: Emapalumab Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study NCT03582800Phase 211 sites📍 Bordeaux📍 Bron📍 Le Kremlin-Bicêtre University Hospital, Limoges · Tests: STS Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis NCT06462768n/a1 site📍 Reims CHU de Reims · Tests: Blood sample Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation NCT07037472NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: Multi-modal photoacoustic/ultrasonic (PA/US) imaging system, Drug treatment Descartes-08 in Autoantibody Myositis NCT07391605Phase 24 sites📍 Orange📍 Boston📍 Chapel Hill Cartesian Therapeutics · Tests: Descartes-08, Placebo Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis NCT06857240Phase 21 site📍 Cleveland The Cleveland Clinic · Tests: Ruxolitinib Topical Cream Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis NCT06298019Phase 12 sites📍 Palo Alto📍 Stanford Stanford University · Tests: KYV-101 Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease NCT06203249n/a1 site📍 Beijing Chinese PLA General Hospital A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 NCT07403188n/a1 site📍 Denver Kyverna Therapeutics · Tests: KYV-101 FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) NCT07111065Phase 21 site📍 Bethesda National Institute of Environmental Health Sciences (NIEHS) · Tests: FISH OIL 500MG OMEGA-3 SOFT GEL MINIS, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy